Article: A személyre szabott medicina, a biomarker-kutatás és a gyógyszerfejlesztés új irányai.
2013 Volume 57, Issue 1, Page(s) 5–10
Abstract: In recent years, medicine has taken some important first steps toward a major paradigm shift that could result in a landslide for personalized therapies. Indeed, evidence-based medicine seems to yield to personalized medicine in multiple areas, including ...
Title translation | New directions in biomarker research, drug development and personalized medicine. |
---|---|
Abstract | In recent years, medicine has taken some important first steps toward a major paradigm shift that could result in a landslide for personalized therapies. Indeed, evidence-based medicine seems to yield to personalized medicine in multiple areas, including both the thinking patterns of healthcare workers and everyday medical practice. Nevertheless, although a steadily increasing number of personalized treatment modalities have recently become available for patients, so far, no breakthrough can be seen in the paradigm shift from evidence-based medicine to personalized therapy. We believe that a more efficient identification and utilisation of future and already known biomarkers, respectively, might be the key to speed up this progress. In line with this, biomarkers are becoming increasingly important tools in late stage research, drug development and in clinical practice, as well. Correct classification of biomarkers becomes especially important, as different types of biomarkers provide markedly different information to drug developers and health care professionals. |
MeSH term(s) | Biomarkers ; Biomarkers, Tumor ; Chronic Disease/drug therapy ; Drug Design ; Evidence-Based Medicine ; Humans ; Molecular Targeted Therapy/trends ; Neoplasms/diagnosis ; Neoplasms/drug therapy ; Neoplasms/genetics ; Pathology, Molecular ; Pharmacogenetics ; Precision Medicine/trends ; Predictive Value of Tests ; Prognosis ; Reagent Kits, Diagnostic |
Chemical Substances | Biomarkers ; Biomarkers, Tumor ; Reagent Kits, Diagnostic |
Language | Hungarian |
Publishing date | 2013-03 |
Publishing country | Hungary |
Document type | English Abstract ; Journal Article ; Review |
ZDB-ID | 414033-3 |
ISSN | 0025-0244 |
ISSN | 0025-0244 |
DOI | MagyOnkol.2013.57.1.5 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5853: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.